Free Trial

Corcept Therapeutics (CORT) SEC Filings & 10K Form

Corcept Therapeutics logo
$67.54 -4.73 (-6.54%)
Closing price 07/7/2025 04:00 PM Eastern
Extended Trading
$67.88 +0.34 (+0.50%)
As of 07/7/2025 07:55 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Corcept Therapeutics SEC Filings

DateFilerForm TypeView
07/03/2025
7:35 PM
Corcept Therapeutics (Issuer)
Maduck Sean (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2025
7:36 PM
Corcept Therapeutics (Issuer)
Lyon Joseph Douglas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2025
7:39 PM
Corcept Therapeutics (Issuer)
Guyer William (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2025
12:52 PM
Corcept Therapeutics (Subject)
Guyer William (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/01/2025
1:01 PM
Corcept Therapeutics (Subject)
Lyon Joseph Douglas (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/01/2025
1:09 PM
Corcept Therapeutics (Subject)
Maduck Sean (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/18/2025
5:26 PM
Corcept Therapeutics (Issuer)
Robb Gary Charles (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2025
7:53 PM
Cannon Gillian (Reporting)
Corcept Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2025
7:39 PM
Corcept Therapeutics (Issuer)
MAHONEY DAVID L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2025
7:40 PM
Alton Gregg H (Reporting)
Corcept Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2025
7:41 PM
Corcept Therapeutics (Issuer)
Guyer William (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2025
7:42 PM
Corcept Therapeutics (Issuer)
Swisher Daniel N JR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2025
7:44 PM
Corcept Therapeutics (Issuer)
Park Kimberly (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2025
7:44 PM
Corcept Therapeutics (Issuer)
WILSON JAMES N (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2025
7:46 PM
Corcept Therapeutics (Issuer)
Murray Joshua M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2025
7:08 PM
BAKER G LEONARD JR (Reporting)
Corcept Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2025
10:03 AM
Corcept Therapeutics (Subject)
Swisher Daniel N JR (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/04/2025
7:32 PM
Corcept Therapeutics (Issuer)
Mokari Atabak (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2025
7:32 PM
Corcept Therapeutics (Issuer)
Robb Gary Charles (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2025
7:33 PM
Corcept Therapeutics (Issuer)
Maduck Sean (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2025
7:34 PM
Corcept Therapeutics (Issuer)
Lyon Joseph Douglas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2025
7:41 PM
BELANOFF JOSEPH K (Reporting)
Corcept Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/02/2025
7:57 PM
Corcept Therapeutics (Issuer)
Maduck Sean (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/02/2025
1:31 PM
BELANOFF JOSEPH K (Reporting)
Corcept Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/02/2025
12:59 PM
Corcept Therapeutics (Subject)
Lyon Joseph Douglas (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/02/2025
1:25 PM
Corcept Therapeutics (Subject)
Maduck Sean (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/20/2025
6:35 PM
Corcept Therapeutics (Issuer)
Guyer William (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/20/2025
6:13 PM
Corcept Therapeutics (Issuer)
MAHONEY DAVID L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/20/2025
1:29 PM
Corcept Therapeutics (Subject)
Robb Gary Charles (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/16/2025
1:32 PM
Corcept Therapeutics (Subject)
MAHONEY DAVID L (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/16/2025
12:40 PM
Corcept Therapeutics (Subject)
Guyer William (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/14/2025
4:51 PM
Corcept Therapeutics (Issuer)
Swisher Daniel N JR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/12/2025
9:40 AM
Corcept Therapeutics (Subject)
Swisher Daniel N JR (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/08/2025
7:20 PM
Corcept Therapeutics (Issuer)
Guyer William (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/05/2025
7:33 PM
Corcept Therapeutics (Issuer)
Maduck Sean (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/05/2025
7:26 PM
Corcept Therapeutics (Issuer)
Lyon Joseph Douglas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/05/2025
7:28 PM
BELANOFF JOSEPH K (Reporting)
Corcept Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/02/2025
2:52 PM
Corcept Therapeutics (Subject)
Maduck Sean (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/23/2025
6:41 PM
Corcept Therapeutics (Issuer)
Robb Gary Charles (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/23/2025
6:09 AM
BlackRock, Inc. (Filed by)
Corcept Therapeutics (Subject)
Form SCHEDULE 13G/A
04/14/2025
4:58 PM
Corcept Therapeutics (Issuer)
Swisher Daniel N JR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
This Cold War “Accident” Could Unleash New $100 Trillion AI Boom (Ad)

Obscure Metal More Valuable than Gold and Bitcoin… COMBINED? This strange "AI Metal" holds the key to the $100 trillion AI boom. Which is why Jeff Brown recently traveled to a location that has one of the highest concentrations of this metal in the world. And you won't believe what he uncovered.

Click here to see the details because this could be the biggest tech story of this decade.
04/10/2025
9:07 AM
Corcept Therapeutics (Subject)
Swisher Daniel N JR (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/02/2025
7:01 PM
BELANOFF JOSEPH K (Reporting)
Corcept Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2025
7:08 PM
Corcept Therapeutics (Issuer)
Guyer William (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2025
7:15 PM
Corcept Therapeutics (Issuer)
Lyon Joseph Douglas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2025
7:20 PM
Corcept Therapeutics (Issuer)
Maduck Sean (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/01/2025
2:13 PM
Corcept Therapeutics (Subject)
Lyon Joseph Douglas (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/01/2025
2:23 PM
Corcept Therapeutics (Subject)
Guyer William (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/01/2025
2:00 PM
Corcept Therapeutics (Subject)
Maduck Sean (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/31/2025
7:05 AM
Corcept Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/26/2025
5:55 PM
Corcept Therapeutics (Issuer)
Lyon Joseph Douglas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/26/2025
4:07 PM
Corcept Therapeutics (Issuer)
Maduck Sean (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/26/2025
4:07 PM
BELANOFF JOSEPH K (Reporting)
Corcept Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/24/2025
7:30 PM
Corcept Therapeutics (Issuer)
Robb Gary Charles (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/14/2025
4:30 PM
Corcept Therapeutics (Issuer)
Robb Gary Charles (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2025
3:54 PM
Corcept Therapeutics (Issuer)
Swisher Daniel N JR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/10/2025
10:02 AM
Corcept Therapeutics (Subject)
Swisher Daniel N JR (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/04/2025
7:15 PM
Corcept Therapeutics (Issuer)
Maduck Sean (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
6:53 PM
Corcept Therapeutics (Issuer)
Guyer William (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
6:58 PM
Corcept Therapeutics (Issuer)
Lyon Joseph Douglas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
6:34 PM
Corcept Therapeutics (Issuer)
Mokari Atabak (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
6:38 PM
Corcept Therapeutics (Issuer)
Hunt Hazel (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
6:44 PM
BELANOFF JOSEPH K (Reporting)
Corcept Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
6:27 PM
Corcept Therapeutics (Issuer)
Robb Gary Charles (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
12:59 PM
Corcept Therapeutics (Subject)
Guyer William (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/03/2025
12:47 PM
BELANOFF JOSEPH K (Reporting)
Corcept Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/03/2025
11:37 AM
Corcept Therapeutics (Subject)
Lyon Joseph Douglas (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/03/2025
11:18 AM
Corcept Therapeutics (Subject)
Maduck Sean (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/26/2025
3:18 PM
Corcept Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/26/2025
3:06 PM
Corcept Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/21/2025
4:23 PM
Corcept Therapeutics (Subject)
INGALLS & SNYDER LLC (Filed by)
Form SCHEDULE 13G/A
02/14/2025
8:08 PM
BELANOFF JOSEPH K (Filed by)
Corcept Therapeutics (Subject)
Form SCHEDULE 13G/A
02/14/2025
3:40 PM
BELANOFF JOSEPH K (Reporting)
Corcept Therapeutics (Issuer)
Form 5
Annual statement of changes in beneficial ownership of securities  
02/13/2025
7:20 PM
Corcept Therapeutics (Issuer)
Hunt Hazel (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2025
7:26 PM
Corcept Therapeutics (Issuer)
Swisher Daniel N JR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/10/2025
10:36 AM
Corcept Therapeutics (Subject)
Swisher Daniel N JR (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/03/2025
12:33 PM
Corcept Therapeutics (Subject)
Maduck Sean (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/03/2025
12:17 PM
Corcept Therapeutics (Subject)
Lyon Joseph Douglas (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/29/2025
3:14 PM
Corcept Therapeutics (Issuer)
WILSON JAMES N (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/24/2025
7:20 PM
Corcept Therapeutics (Issuer)
WILSON JAMES N (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/14/2025
6:30 PM
Corcept Therapeutics (Issuer)
Swisher Daniel N JR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/10/2025
9:49 AM
Corcept Therapeutics (Subject)
Swisher Daniel N JR (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/06/2025
6:59 PM
Corcept Therapeutics (Issuer)
Maduck Sean (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2025
6:15 PM
Corcept Therapeutics (Issuer)
Robb Gary Charles (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2025
6:24 PM
Corcept Therapeutics (Issuer)
Lyon Joseph Douglas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/02/2025
5:03 PM
BAKER G LEONARD JR (Reporting)
Corcept Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/02/2025
11:03 AM
Corcept Therapeutics (Subject)
Maduck Sean (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/02/2025
10:52 AM
Corcept Therapeutics (Subject)
Lyon Joseph Douglas (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/02/2025
10:58 AM
Corcept Therapeutics (Subject)
Robb Gary Charles (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/31/2024
3:41 PM
Corcept Therapeutics (Issuer)
WILSON JAMES N (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/30/2024
4:20 PM
Corcept Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
Think you missed gold’s boom? Think again (Ad)

If you've been watching gold's historic run and wondering if it's too late… I've got good news. Because there's a $15 fund tied directly to gold's surge that's still paying massive income… Up to 64% annually — with payouts every 30 days.

Click here to see how to secure the next payout before it's too late.
12/12/2024
3:59 PM
Corcept Therapeutics (Issuer)
Swisher Daniel N JR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/10/2024
9:00 AM
Corcept Therapeutics (Subject)
Swisher Daniel N JR (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/26/2024
5:13 PM
Corcept Therapeutics (Issuer)
Lyon Joseph Douglas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/26/2024
5:16 PM
Corcept Therapeutics (Issuer)
Robb Gary Charles (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/22/2024
1:36 PM
Corcept Therapeutics (Subject)
Lyon Joseph Douglas (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/22/2024
10:41 AM
Corcept Therapeutics (Subject)
Robb Gary Charles (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/13/2024
7:06 PM
Corcept Therapeutics (Issuer)
Swisher Daniel N JR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/05/2024
6:48 PM
Corcept Therapeutics (Issuer)
Guyer William (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/01/2024
11:55 AM
Corcept Therapeutics (Subject)
Guyer William (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:CORT) was last updated on 7/8/2025 by MarketBeat.com Staff
From Our Partners